IA
NMTR

IFP Advisors’s 9 Meters Biopharma NMTR Stock Holding History

IFP Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$1K – 3526
2021
Q3 		$1K Hold
1
– – ﹤0.01% 3191
2021
Q2 		$0 Hold
1
– – ﹤0.01% 3294
2021
Q1 		$0 Hold
1
– – ﹤0.01% 3279
2020
Q4 		$0 Hold
1
– – ﹤0.01% 3139
2020
Q3 		$0 Hold
1
– – ﹤0.01% 3045
2020
Q2 		$0 Hold
1
– – ﹤0.01% 3009
2020
Q1 		$0 Hold
1
– – ﹤0.01% 3063
2019
Q4 		$0 Hold
1
– – ﹤0.01% 3187
2019
Q3 		$0 Buy
+1
New +$20 ﹤0.01% 3164
2019
Q1 		– Sell
-26
Closed -$1K – 3610
2018
Q4 		$1K Hold
26
– – ﹤0.01% 3431
2018
Q3 		$4K Hold
26
– – ﹤0.01% 3351
2018
Q2 		$12K Buy
26
+16
+160% +$5.89K ﹤0.01% 2803
2018
Q1 		$0 Buy
10
+9
+900% +$1.75K ﹤0.01% 3861
2017
Q4 		$0 Hold
1
– – ﹤0.01% 4174
2017
Q3 		$0 Hold
1
– – ﹤0.01% 4260
2017
Q2 		$0 Buy
+1
New +$140 ﹤0.01% 4259

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors's NMTR Position: Q4 2021 in Review

IFP Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2021, closing a stake of 1 share — an estimated $1K sold.

IFP Advisors first reported a position in NMTR in Q2 2017 and held it in 16 quarters. The position peaked at $12K in Q2 2018. 104 funds tracked by Wall St. Rank hold NMTR as of Q4 2021.

  • IFP Advisors reported no remaining 9 Meters Biopharma position as of Q4 2021 after selling out during the quarter.
  • IFP Advisors sold 1 9 Meters Biopharma share in Q4 2021, an estimated $1K.
  • IFP Advisors first reported a position in 9 Meters Biopharma in Q2 2017 and held it in 16 quarters.
  • IFP Advisors's 9 Meters Biopharma position peaked at $12K in Q2 2018.
  • 104 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2021.

Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.